Lipum AB (publ) (STO:LIPUM)
Sweden · Delayed Price · Currency is SEK 14.55
+0.25 (1.75%)
Feb 26, 2026, 4:39 PM CET
Lipum AB Market Cap
Lipum AB has a market cap or net worth of 303.34 million as of February 26, 2026.
Market Cap
303.34M
Enterprise Value
301.78M
Revenue
1.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.55
Market Cap Chart
Since April 22, 2021, Lipum AB's market cap has increased from 114.77M to 303.34M, an increase of 164.31%. That is a compound annual growth rate of 22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 308.64M | -0.34% |
| Dec 30, 2025 | 309.70M | 21.67% |
| Dec 30, 2024 | 254.55M | 319.14% |
| Dec 29, 2023 | 60.73M | -43.12% |
| Dec 30, 2022 | 106.78M | 14.23% |
| Dec 30, 2021 | 93.47M | -18.56% |
| Apr 22, 2021 | 114.77M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 389.33M |
| Ascelia Pharma AB | 386.32M |
| Elicera Therapeutics AB | 308.69M |
| Mendus AB | 295.09M |
| Bio-Works Technologies AB | 294.30M |
| Xintela AB | 241.15M |
| Intervacc AB | 238.57M |
| Sprint Bioscience AB | 234.24M |